What is Direct Effects?

Direct Effects  is a ground-breaking patented method of delivering neuro-active drugs, traditional pharmaceuticals as well as herbal and natural compounds such as CBD/cannabidiol and other cannabinoids, to treat brain and peripheral neuropathic conditions without systemic effects. This not only reduces potential side effects and drug interactions of systemic bloodstream dependent therapy, but therapeutic benefits are realized well within 10-15 minutes as direct nerve connections are involved.

In the 30 different compounds tested to date with the Direct Effects ™ technology, the time to achieve benefit was the same, alluding to the fact that our peripheral nerve conduction back to the central nervous system, CNS, is about the same for all individuals. With oral and other systemic deliveries relying on blood; one has to consider gastrointestinal transit, absorption, liver first pass metabolism, heart function, and other blood flow factors which differ from person to person, and even, from time to time. Further, there is also no potential for overdose as drug blood levels are non-existent or negligible.

Patented Breakthroughs

Dr. Aung-Din has been granted 13 US and foreign patents related to DirectEffects delivery.

Of particular significance are 5 recent USPTO patented breakthroughs.

#1: CBD/cannabinoids in humans

#2: Using CBD/cannabinoids in animals/veterinary medicine

#3: Using CBD/cannabinoids combined with a traditional pharmaceutical agent

#4: Using CBD/cannabinoids combined with another therapeutic herbal/natural compound

#5: Using the non-cannabis cannabinoid-receptor agonist, caryophyllene*

*Particularly useful for fibromyalgia and neuropathic pain conditions. It also avoids the stigma and misconceptions still existing with CBD and other traditional cannabis products. Caryophyllene is derived from essential oil extracts of such innocuous substances such as African Black pepper, cloves, and lavender.


Tom: Vietnam veteran with intractable chronic migraines and neck pain.

Sebastian: Young boy with myoclonic epilepsy

Cocoa: Dachshund with degenerative disc disorder

Aidan: Young boy with febrile and grand mall seizures